Gritstone Oncology Inc buy BiotechBee
Start price
24.12.23
/
50%
€1.83
Target price
31.08.25
€3.00
Performance (%)
-47.35%
End price
07.04.24
€0.96
Summary
This prediction ended on 07.04.24 with a price of €0.96. The BUY prediction by BiotechBee for Gritstone Oncology Inc performed very badly with a performance of -47.35%. BiotechBee has a follow-up prediction for Gritstone Oncology Inc where he still thinks Gritstone Oncology Inc is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Gritstone Oncology Inc | -62.176% | -62.176% |
| iShares Core DAX® | 1.164% | 1.549% |
| iShares Nasdaq 100 | 0.118% | 0.969% |
| iShares Nikkei 225® | 1.124% | -1.120% |
| iShares S&P 500 | 0.479% | 1.068% |
According to BiotechBee what are the pros and cons of Gritstone Oncology Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Gritstone Oncology Inc diskutieren
In the thread Trading Gritstone Oncology Inc
Current prediction by BiotechBee for Gritstone Oncology Inc
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€0.43
08.09.24
08.09.24
€1.50
31.01.27
31.01.27
-53.10%
10:22
10:22
Could be very worthwhile Investment >20% year
